The International Myeloma Working Group (IMWG) has provided expert consensus clinical practice guidelines for the use of bispecific antibodies for the treatment of myeloma.
Click here to learn more about adverse event management for bispecific antibodies as recommended by the IMWG.
Connect With My Medical Science Liaison
Chat Live
Available Monday - Friday 9AM - 4:30PM ET
Call Me Now
Available Monday - Friday 9AM - 7:30PM ET
Email Your Inquiry
Call 1-800-JANSSEN
Available Monday - Friday 9AM - 8PM ET
Live Video